Literature DB >> 30713013

Adherence to Long-Term Oxygen Therapy. Influence of Tobacco Use.

Enrique Barrueco-Otero1, María Bartol Sánchez2, Javier Pérez Rodríguez3, José María González Ruiz4, Miguel Barrueco Ferrero5.   

Abstract

INTRODUCTION: Domiciliary oxygen therapy (DOT) is a treatment that requires a high level of cooperation from patients due to the time it takes every day. A high level of non-compliance has been determined among patients receiving DOT. The aim of our study was to assess the level of non-compliance and the influence of active tobacco consumption on compliance.
MATERIAL AND METHODS: Patients were monitored in the home using direct and indirect methods, to assess both compliance and tobacco consumption.
RESULTS: The level of non-compliance detected by indirect methods was 22.6%, and 66.3% by direct methods. Tobacco consumption determined by indirect methods was 5.8%-8%, depending on the method used, and 16.2% when CO in exhaled air ≥10ppm was established as an indicator of tobacco use. The group of smokers complied with oxygen therapy for a significantly fewer number of hours per day (P<.001) than non-smokers.
CONCLUSIONS: There is a high level of therapeutic non-compliance and a significant percentage of patients receiving DOT continue to smoke. Compliance must be monitored, and the correct use of DOT must be emphasized. Additional efforts should also be made to help smokers with DOT to stop smoking, since continued smoking impacts negatively on therapeutic non-compliance. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Compliance; Cumplimiento; Oxigenoterapia; Oxygen therapy; Smoking; Tabaquismo

Mesh:

Substances:

Year:  2019        PMID: 30713013     DOI: 10.1016/j.arbres.2018.12.005

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  [Do COPD patients lie about their smoking habit?]

Authors:  Virginia Almadana Pacheco; Cristina Benito Bernáldez; Estefanía Luque Crespo; Rafael Perera Louvier; Julio César Rodríguez Fernández; Agustín S Valido Morales
Journal:  Aten Primaria       Date:  2020-07-30       Impact factor: 1.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.